review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0950-3579(05)80249-3 |
P698 | PubMed publication ID | 2282661 |
P2093 | author name string | Brooks PM | |
Needs CJ | |||
P2860 | cites work | Persistent pulmonary hypertension and abnormal prostaglandin E levels in preterm infants after maternal treatment with naproxen | Q28329006 |
Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn | Q28334845 | ||
Adrenocorticosteroid therapy in pregnancy | Q33475001 | ||
Cyclophosphamide in human milk | Q34201855 | ||
Accumulation of chorio-retinotoxic drugs in the foetal eye. | Q34234023 | ||
Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women | Q34235675 | ||
Secretion of prednisolone into breast milk | Q34988178 | ||
Fetal effects of regular salicylate ingestion in pregnancy | Q39342350 | ||
Propoxyphene and acetaminophen. Possible effects on the fetus | Q39355315 | ||
Drugs in pregnancy: effects on the fetus and newborn | Q39553659 | ||
Excretion of ibuprofen into breast milk | Q39554388 | ||
Antirheumatic drug treatment during pregnancy and lactation | Q39821365 | ||
Antirheumatic medication in pregnancy | Q39824193 | ||
Antirheumatic medication during lactation | Q39824200 | ||
Action of chloroquine phosphate in rheumatoid arthritis. II. Chromosome damaging effect | Q41317103 | ||
Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors | Q41379010 | ||
THE OTOTOXICITY OF CHLOROQUINE PHOSPHATE. | Q41943335 | ||
Possible teratogenicity of sulphasalazine | Q42241861 | ||
Analgesic drugs in breast milk and plasma | Q42267758 | ||
Excretion of hydroxychloroquine in human milk | Q42532068 | ||
Pregnancy and cystinuria | Q43732358 | ||
Placental and mammary transfer of sulphasalazine | Q50284495 | ||
Reduction in oral penicillamine absorption by food, antacid, and ferrous sulfate. | Q51647341 | ||
Associations Between Oral Clefts and Drugs Taken During Pregnancy | Q52718485 | ||
Penicillamine in pregnancy | Q66698078 | ||
Convulsions in a breast-fed infant after maternal indomethacin | Q66699952 | ||
??? | Q28326859 | ||
Medical innumeracy | Q66706099 | ||
Transfer of gold from mother to fetus | Q66706348 | ||
Aspirin: Teratogenic evaluation in the dog | Q66983032 | ||
Studies on closure of the ductus arteriosus. XII. In utero effect of indomethacin and sodium salicylate in rats and rabbits | Q67510740 | ||
Neonatal abnormalities associated with D-penicillamine treatment during pregnancy | Q67536797 | ||
Piroxicam in breast milk after long-term treatment | Q68047188 | ||
Neonatal withdrawal symptoms associated with maternal use of propoxyphene hydrochloride (Darvon) | Q68535854 | ||
Associations between drugs administered during pregnancy and congenital abnormalities of the fetus | Q68751892 | ||
Studies on closure of the ductus arteriosus. XI. Ductal closure in utero by a prostaglandin synthetase inhibitor | Q68882542 | ||
Section 2 A profile of the physiological disposition and gastro-intestinal effects of fenoprofen in man | Q69365673 | ||
Hyponatremia and fluid retention in a neonate associated with maternal naproxen overdosage | Q69551847 | ||
Teratogen update: penicillamine | Q69581020 | ||
Letter: Metabolism of gold during lactation | Q69617570 | ||
Sulphasalazine and sulphapyridine serum levels in children to mothers treated with sulphasalazine during pregnancy and lactation | Q69897264 | ||
Influence of acetylsalicylic acid, an inhibitor of prostaglandin synthesis, on the duration of human gestation and labour | Q70003364 | ||
Drugs ingested by pregnant women | Q70038107 | ||
Outcome for the foetus of mothers receiving prednisolone during pregnancy | Q70081221 | ||
Excretion of gold into human breast milk | Q70321482 | ||
Propoxyphene and Congenital Malformations | Q70575293 | ||
Systemic Lupus Erythematosus in Pregnancy | Q70783931 | ||
Excretion of paracetamol in human breast milk | Q70870816 | ||
D-penicillamine in pregnancy — to ban or not to ban? | Q70881759 | ||
Naproxen excretion in milk and its uptake by the infant | Q71141912 | ||
Piroxicam in human breast milk | Q71166892 | ||
Effect of pregnancy in patients with lupus nephropathy | Q71406876 | ||
Infants of mothers receiving gold therapy | Q71504972 | ||
Salicylate-induced fetal death and malformations in two mouse strains | Q72176421 | ||
Placental Transfer of Sulphasalazine and Sulphapyridine and Some of Its Metabolites | Q72518731 | ||
Inflammatory Bowel Disease and Pregnancy | Q72530296 | ||
Cortisone-induced congenital cleft palate in rabbits | Q73616276 | ||
Plasma cholinesterase activity in normal pregnance and in eclamptogenic toxemias | Q73814086 | ||
The effect of pregnancy on gastric secretion | Q74308541 | ||
WASTING DISEASE INDUCED IN YOUNG MICE BY ADMINISTRATION OF CORTISOL ACETATE | Q76642610 | ||
Pregnancy and adrenocortical hormones. Some aspects of their interaction in rheumatic diseases | Q79055772 | ||
Steroids during pregnancy and possible fetal consequences | Q79167072 | ||
Effects of cancer chemotherapeutic agents on the human fetus | Q79268547 | ||
P433 | issue | 1 | |
P304 | page(s) | 157-171 | |
P577 | publication date | 1990-04-01 | |
P1433 | published in | Bailliere's clinical rheumatology | Q27710332 |
P1476 | title | Antirheumatic drugs in pregnancy and lactation | |
P478 | volume | 4 |
Search more.